Observational studyMedicina (Kaunas, Lithuania)2026
Real-World Faricimab for Treatment-Naïve Neovascular AMD and Diabetic Macular Edema: 24-Month Outcomes from a Single-Center Pilot Cohort in South-Eastern Europe.
Maja L J Živković et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.